MX2010001187A - Moduladores del receptor ccr9 y metodos para su uso. - Google Patents
Moduladores del receptor ccr9 y metodos para su uso.Info
- Publication number
- MX2010001187A MX2010001187A MX2010001187A MX2010001187A MX2010001187A MX 2010001187 A MX2010001187 A MX 2010001187A MX 2010001187 A MX2010001187 A MX 2010001187A MX 2010001187 A MX2010001187 A MX 2010001187A MX 2010001187 A MX2010001187 A MX 2010001187A
- Authority
- MX
- Mexico
- Prior art keywords
- methods
- modulators
- ccr9 receptor
- compounds
- ccr9
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D333/40—Thiophene-2-carboxylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D333/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D333/70—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US96264007P | 2007-07-30 | 2007-07-30 | |
| PCT/US2008/009142 WO2009017719A2 (fr) | 2007-07-30 | 2008-07-28 | Modulateurs du récepteur ccr9 et leurs procédés d'utilisation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2010001187A true MX2010001187A (es) | 2010-03-04 |
Family
ID=40305125
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2010001187A MX2010001187A (es) | 2007-07-30 | 2008-07-28 | Moduladores del receptor ccr9 y metodos para su uso. |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP2220065A2 (fr) |
| KR (1) | KR20100033418A (fr) |
| AU (1) | AU2008282903B2 (fr) |
| CA (1) | CA2692013C (fr) |
| MX (1) | MX2010001187A (fr) |
| SG (1) | SG183667A1 (fr) |
| WO (1) | WO2009017719A2 (fr) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI1006128A2 (pt) | 2009-01-12 | 2016-11-01 | Cagen Inc | derivados de sulfonamida |
| JP2013525368A (ja) * | 2010-04-23 | 2013-06-20 | キネタ・インコーポレイテツド | 抗ウイルス性化合物 |
| EP2590972B1 (fr) | 2010-07-09 | 2015-01-21 | Pfizer Limited | N-sulfonylbenzamides comme inhibiteurs des canaux sodiques voltage-dépendant |
| MX339201B (es) * | 2010-10-12 | 2016-05-13 | Zafgen Inc | Compuestos de sulfonamida y métodos para elaborarlos y usarlos. |
| TW201512171A (zh) | 2013-04-19 | 2015-04-01 | Pfizer Ltd | 化學化合物 |
| EP4424681A1 (fr) * | 2021-10-28 | 2024-09-04 | Shikoku Chemicals Corporation | Composé thiophène, son procédé de synthèse et composition contenant ledit composé thiophène |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001503037A (ja) * | 1996-10-16 | 2001-03-06 | アメリカン・サイアナミド・カンパニー | マトリクス金属プロテナイーゼおよびｔａｃｅに対する阻害薬としてのオルト―スルホンアミドヘテロアリールヒドロキサム酸の製造および使用 |
| JP3972163B2 (ja) * | 1999-06-18 | 2007-09-05 | 株式会社大塚製薬工場 | ホスホン酸ジエステル誘導体 |
| EP1610753A4 (fr) * | 2003-02-20 | 2007-07-04 | Encysive Pharmaceuticals Inc | Antagonistes du recepteur de l'urotensine-ii de la phenylenediamine et antagonistes du ccr-9 |
-
2008
- 2008-07-28 WO PCT/US2008/009142 patent/WO2009017719A2/fr active Application Filing
- 2008-07-28 AU AU2008282903A patent/AU2008282903B2/en not_active Ceased
- 2008-07-28 MX MX2010001187A patent/MX2010001187A/es not_active Application Discontinuation
- 2008-07-28 SG SG2012056255A patent/SG183667A1/en unknown
- 2008-07-28 EP EP08794832A patent/EP2220065A2/fr not_active Withdrawn
- 2008-07-28 CA CA2692013A patent/CA2692013C/fr not_active Expired - Fee Related
- 2008-07-28 KR KR1020107001995A patent/KR20100033418A/ko not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2692013A1 (fr) | 2009-02-05 |
| WO2009017719A2 (fr) | 2009-02-05 |
| CA2692013C (fr) | 2012-08-28 |
| AU2008282903A1 (en) | 2009-02-05 |
| KR20100033418A (ko) | 2010-03-29 |
| WO2009017719A8 (fr) | 2010-02-11 |
| SG183667A1 (en) | 2012-09-27 |
| EP2220065A2 (fr) | 2010-08-25 |
| WO2009017719A3 (fr) | 2009-04-23 |
| AU2008282903B2 (en) | 2011-06-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NL301145I1 (fr) | ||
| MX2009006812A (es) | Moduladores del receptor c3a y metodos de uso de los mismos. | |
| PH12020550450A1 (en) | Certain chemical entities, compositions and methods | |
| TN2010000122A1 (en) | Compounds and compositions as modulators of gpr119 activity | |
| MX2009009491A (es) | Compuestos y composiciones como moduladores de la actividad del gpr119. | |
| EA201001329A1 (ru) | Соединения и композиции в качестве модуляторов активности gpr119 | |
| EP2542254A4 (fr) | Modulateurs des récepteurs nmda à structure secondaire stabilisée et leurs utilisations | |
| TW200716624A (en) | Compounds for modulating TRPV3 function | |
| MY159955A (en) | Certain chemical entities, compositions and methods | |
| TW200801021A (en) | Imidazolothiazole compounds for the treatment of disease | |
| WO2009044173A3 (fr) | Procédés de traitement du cancer à l'aide d'inhibiteurs de la voie de notch | |
| EA201001332A1 (ru) | Соединения и композиции в качестве модуляторов активности gpr119 | |
| MX2011006150A (es) | Compuestos inhibidores de cinasa. | |
| PH12020551140A1 (en) | Spiro-lactam nmda receptor modulators and uses thereof | |
| EA201001330A1 (ru) | Соединения и композиции в качестве модуляторов активности gpr119 | |
| MX2012004078A (es) | Compuestos y composiciones como moduladores de la actividad de gpr119. | |
| MX2010002028A (es) | Metodos y composiciones para modular celulas t. | |
| MX2010006206A (es) | Derivados de oxindol substituidos por 5-halogeno y el uso de los mismos para el tratamiento de enfermedades dependientes de la vasopresina. | |
| MX2010001187A (es) | Moduladores del receptor ccr9 y metodos para su uso. | |
| HK1155943A1 (en) | Combination of a nicotinic receptor partial agonist and of an acetylcholinesterase inhibitor, pharmaceutical composition containing same and use thereof in the treatment of cognitive disorders | |
| IN2012DN03844A (fr) | ||
| AU316238S (en) | Lawning applicator for microbiological cultures | |
| MY157007A (en) | Novel possibility of controlling giardiosis | |
| EP1898950A4 (fr) | Galk1s modificateurs de la voie pten/akt et méthodes d'utilisation | |
| EP2547203A4 (fr) | Modulateurs ccr5 pour traiter le vih |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |